Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target

Lipid metabolism is known to be involved in tumorigenesis and disease progression in many common cancer types, including colon, lung, breast and prostate, through modifications of lipid synthesis, storage and catabolism. Furthermore, lipid alterations may arise as a consequence of cancer treatment a...

Full description

Bibliographic Details
Main Authors: Roberta Modica, Anna La Salvia, Alessia Liccardi, Giuseppe Cannavale, Roberto Minotta, Elio Benevento, Antongiulio Faggiano, Annamaria Colao
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/12/11/1057
_version_ 1827646117674745856
author Roberta Modica
Anna La Salvia
Alessia Liccardi
Giuseppe Cannavale
Roberto Minotta
Elio Benevento
Antongiulio Faggiano
Annamaria Colao
author_facet Roberta Modica
Anna La Salvia
Alessia Liccardi
Giuseppe Cannavale
Roberto Minotta
Elio Benevento
Antongiulio Faggiano
Annamaria Colao
author_sort Roberta Modica
collection DOAJ
description Lipid metabolism is known to be involved in tumorigenesis and disease progression in many common cancer types, including colon, lung, breast and prostate, through modifications of lipid synthesis, storage and catabolism. Furthermore, lipid alterations may arise as a consequence of cancer treatment and may have a role in treatment resistance. Neuroendocrine neoplasms (NENs) are a heterogeneous group of malignancies with increasing incidence, whose mechanisms of cancer initiation and progression are far from being fully understood. Alterations of lipid metabolism may be common across various cancer types, but data about NENs are scattered and heterogeneous. Herein, we provide an overview of the relevant literature on lipid metabolism and alterations in NENs. The available evidence both in basic and clinical research about lipid metabolism in NENs, including therapeutic effects on lipid homeostasis, are summarized. Additionally, the potential of targeting the lipid profile in NEN therapy is also discussed, and areas for further research are proposed.
first_indexed 2024-03-09T18:50:32Z
format Article
id doaj.art-0b84c308d21c4fa39ab39376ba534901
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-09T18:50:32Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-0b84c308d21c4fa39ab39376ba5349012023-11-24T05:50:20ZengMDPI AGMetabolites2218-19892022-11-011211105710.3390/metabo12111057Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic TargetRoberta Modica0Anna La Salvia1Alessia Liccardi2Giuseppe Cannavale3Roberto Minotta4Elio Benevento5Antongiulio Faggiano6Annamaria Colao7Department of Clinical Medicine and Surgery, Endocrinology Unit of Federico II University of Naples, 80131 Naples, ItalyDivision of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, ItalyDepartment of Clinical Medicine and Surgery, Endocrinology Unit of Federico II University of Naples, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, Endocrinology Unit of Federico II University of Naples, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, Endocrinology Unit of Federico II University of Naples, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, Endocrinology Unit of Federico II University of Naples, 80131 Naples, ItalyEndocrinology Unit, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, 00189 Rome, ItalyDepartment of Clinical Medicine and Surgery, Endocrinology Unit of Federico II University of Naples, 80131 Naples, ItalyLipid metabolism is known to be involved in tumorigenesis and disease progression in many common cancer types, including colon, lung, breast and prostate, through modifications of lipid synthesis, storage and catabolism. Furthermore, lipid alterations may arise as a consequence of cancer treatment and may have a role in treatment resistance. Neuroendocrine neoplasms (NENs) are a heterogeneous group of malignancies with increasing incidence, whose mechanisms of cancer initiation and progression are far from being fully understood. Alterations of lipid metabolism may be common across various cancer types, but data about NENs are scattered and heterogeneous. Herein, we provide an overview of the relevant literature on lipid metabolism and alterations in NENs. The available evidence both in basic and clinical research about lipid metabolism in NENs, including therapeutic effects on lipid homeostasis, are summarized. Additionally, the potential of targeting the lipid profile in NEN therapy is also discussed, and areas for further research are proposed.https://www.mdpi.com/2218-1989/12/11/1057lipid metabolismcholesterolmetabolic syndromeneuroendocrine neoplasmneuroendocrine tumorcancer
spellingShingle Roberta Modica
Anna La Salvia
Alessia Liccardi
Giuseppe Cannavale
Roberto Minotta
Elio Benevento
Antongiulio Faggiano
Annamaria Colao
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
Metabolites
lipid metabolism
cholesterol
metabolic syndrome
neuroendocrine neoplasm
neuroendocrine tumor
cancer
title Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
title_full Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
title_fullStr Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
title_full_unstemmed Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
title_short Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
title_sort lipid metabolism and homeostasis in patients with neuroendocrine neoplasms from risk factor to potential therapeutic target
topic lipid metabolism
cholesterol
metabolic syndrome
neuroendocrine neoplasm
neuroendocrine tumor
cancer
url https://www.mdpi.com/2218-1989/12/11/1057
work_keys_str_mv AT robertamodica lipidmetabolismandhomeostasisinpatientswithneuroendocrineneoplasmsfromriskfactortopotentialtherapeutictarget
AT annalasalvia lipidmetabolismandhomeostasisinpatientswithneuroendocrineneoplasmsfromriskfactortopotentialtherapeutictarget
AT alessialiccardi lipidmetabolismandhomeostasisinpatientswithneuroendocrineneoplasmsfromriskfactortopotentialtherapeutictarget
AT giuseppecannavale lipidmetabolismandhomeostasisinpatientswithneuroendocrineneoplasmsfromriskfactortopotentialtherapeutictarget
AT robertominotta lipidmetabolismandhomeostasisinpatientswithneuroendocrineneoplasmsfromriskfactortopotentialtherapeutictarget
AT eliobenevento lipidmetabolismandhomeostasisinpatientswithneuroendocrineneoplasmsfromriskfactortopotentialtherapeutictarget
AT antongiuliofaggiano lipidmetabolismandhomeostasisinpatientswithneuroendocrineneoplasmsfromriskfactortopotentialtherapeutictarget
AT annamariacolao lipidmetabolismandhomeostasisinpatientswithneuroendocrineneoplasmsfromriskfactortopotentialtherapeutictarget